Join Us: Webinar on Decontaminating Respirators for Health Care Personnel Use during the COVID-19 Pandemic

On Tuesday, July 7, 12:00 p.m.-1:00 p.m. ET, the U.S. Food and Drug Administration (FDA), along with the Centers for Disease Control and Prevention's (CDC) National Institute for Occupational Safety and Health (NIOSH) and the Occupational Safety and Health Administration (OSHA), will host a webinar on Decontaminating Respirators for Health Care Personnel Use during the COVID-19 Pandemic. This webinar is the third in the respirator webinar series.

During this webinar:

The FDA will speak in detail about decontamination systems for respirators, including:
Specific methods of decontamination,
Evidence of potential effectiveness, and
Best practices and common challenges in Emergency Use Authorization (EUA) request submissions.
The FDA will answer the top questions we’re hearing related to decontaminating respirators.
Representatives from the FDA, the CDC, and OSHA will respond to questions from webinar attendees about the safe use of respirators by healthcare personnel during the COVID-19 pandemic.

We encourage all interested stakeholders to join. Registration is not necessary.

Hear from speakers, including:

Elizabeth F. Claverie-Williams, MS, CAPT, USPHS-CC, Assistant Director, Disinfection, Reprocessing, and Personal Protection team, FDA/CDRH Office of Product Evaluation and Quality (OPEQ)
Clarence W. Murray, III, Ph.D., Team Leader, Sterility Devices Team, FDA/CDRH Office of Product Evaluation and Quality (OPEQ)
Jon W. Weeks, Ph.D., Scientific Reviewer, FDA/CDRH Office of Science and Engineering Laboratories (OSEL)

View the Webinar Details

SAVE THE DATE:

The FDA also plans to hold additional webinars every two weeks to continue to share information and answer your questions on respirators and other personal protective equipment (PPE). Save the date for the next webinar: